Helicobacter Infections: Clinical Trials

11 trials for Helicobacter Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed. 11 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 411Completed 11

Follow Helicobacter Infections: new trials by email Literature Review of Helicobacter Infections trials Research Report on Helicobacter Infections

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intraluminal Therapy for Helicobacter Pylori Infection
Lansoprazole, Amoxicillin, Clarithromycin - Helicobacter Pylori Infection
Phase 4CompletedMackay Memorial Hospital1002017-04-282018-05-02
Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection
Nexium, Tinafas, Tavanex - Helicobacter Infection
Phase 4CompletedZahra Vahdat Shariatpanahi2122016-09-012017-06-08
Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection
Ilaprazole + Amoxicillin - Helicobacter Infections
Phase 4CompletedIl-Yang Pharm. Co., Ltd.902014-12-012015-11-03
Efficacy on Helicobacter Pylori Eradication With Two Antibiotic Regimens
Sequential therapy, Triple therapy - Helicobacter Infections
Phase 4CompletedCoordinación de Investigación en Salud, Mexico1422013-03-012015-03-23
A Trial of Standard vs Half Dose Rabeprazole, Clarithromycin, Metronidazole and Amoxicillin in the Treatment of Helicobacter Pylori Infection
Rabeprazole, metronidazole, Clarithromycin, Amoxicillin - Helicobacter Infections
Phase 4CompletedAmerican University of Beirut Medical Center2002010-10-012014-01-27
Efficacy of High Dose Dual Therapy, Sequential Therapy and Triple Therapy in H. Pylori Eradication
high dose dual therapy, sequential therapy, clarithromycin-based triple therapy - Helicobacter Infection
Phase 4CompletedNational Taiwan University Hospital6182010-08-012013-12-03
Comparison of 7-day and 14-day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori Eradication
pantoprazole, bismuth, metronidazole - Helicobacter Infection
Phase 4CompletedAsan Medical Center1992008-06-012016-12-06
Levofloxacin Versus Clarithromycin Triple Therapy in First-Line Treatment for Helicobacter Pylori Eradication
Cravit based triple therapy, Klaricid based triple therapy - Helicobacter Infections
Phase 4CompletedNational Taiwan University Hospital4322007-06-012011-04-22
Comparison of Sequential or Concomitant Therapy for Helicobacter Pylori Infection
10-day sequential treatment, 10-day concomitant therapy - Helicobacter Infection
Phase 4CompletedKaohsiung Veterans General Hospital.2322007-05-012015-09-30
Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.
rabeprazole sodium - Helicobacter Infections, Bacterial Infections
Phase 4CompletedJanssen Cilag Pharmaceutica S.A.C.I., Greece802004-10-012010-04-26
Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy
esomeprazole, tripotassium dicitrate bismuthate, metronidazole - Helicobacter Infections
Phase 4CompletedSeoul National University Bundang Hospital6482003-01-012013-02-15

Narrower conditions

Bacterial Infections (1)  ·  Peptic Ulcer (1)  ·  Stomach Neoplasms (1)

Broader conditions

Bacterial Infections and Mycoses (11)  ·  Gram-Negative Bacterial Infections (11)  ·  Infections (11)  ·  Bacterial Infections (10)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Duodenal Diseases (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Intestinal Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Stomach Diseases (1)

Interventions

Amoxicillin (5)  ·  Clarithromycin (3)  ·  Metronidazole (3)  ·  Esomeprazole (2)  ·  Lansoprazole (2)  ·  Rabeprazole (2)  ·  Tetracycline (2)  ·  Bismuth (1)  ·  Moxifloxacin (1)  ·  Pantoprazole (1)  ·  Tinidazole (1)  ·  ilaprazole (1)

Sponsors

National Taiwan University Hospital (2)  ·  American University of Beirut Medical Center (1)  ·  Asan Medical Center (1)  ·  Coordinación de Investigación en Salud, Mexico (1)  ·  Il-Yang Pharm. Co., Ltd. (1)  ·  Janssen Cilag Pharmaceutica S.A.C.I., Greece (1)  ·  Kaohsiung Veterans General Hospital. (1)  ·  Mackay Memorial Hospital (1)  ·  Seoul National University Bundang Hospital (1)  ·  Zahra Vahdat Shariatpanahi (1)

Countries

Taiwan (4)  ·  South Korea (3)  ·  Iran (1)  ·  Lebanon (1)

Top investigators

Ala' I Sharara, MD (1)  ·  Antone R Opekun, PA-C (1)  ·  Ching-Kuan Liu, MD, PhD (1)  ·  David Y Graham, MD (1)  ·  Deng-Chyang Wu, MD PhD (1)  ·  Hwoon-Yong Jung, M.D (1)  ·  Jawtown Lin (1)  ·  Jyh-Chin Yang, M.D.Ph.D. (1)  ·  Shaahin Shahbazi, MD (1)  ·  Tai-cherng Liou, MD (1)  ·  YoonJeong Lim, MD, PhD (1)

Results publications

PMID 20427390, PMID 21762268, PMID 24050512, PMID 25460556, PMID 30635887, PMID 30734357, PMID 32545856